In various cancer cell lines and in vivo tumor models, resveratrol enhances the antitumor efficacy of rapamycin (An inhibitor of the autophagy inducer of mTORC1) by reducing the autophagy induced by AKT phosphorylation in thyroid cancer (KTC-1 and TPC-1) cells [801]. This evidence concerns the gene AKT1 and neoplasm.